“Bimekizumab speed of response in patients with moderate to severe plaque psoriasis: Results from four phase 3/3b trials (BE VIVID, BE READY, BE SURE, and BE RADIANT)”, J of Skin, vol. 6, no. 6, p. s69, Nov. 2022, doi: 10.25251/skin.6.supp.69.